ResultsIQ

ResultsIQ › Latest results › Chemplast Sanmar Limited

Chemplast Sanmar Limited Q4 FY25 earnings call summary

NSE: CHEMPLASTS · BSE: 543336

Earnings call of 14 May 2025, summarised by AI from the filing.

Chemplast Sanmar FY25 revenue ₹4,346 cr and EBITDA ₹219 cr, with R32 project of ₹340 cr guided for completion by October 2026.

Key takeaways

  1. FY25 results Revenue ₹4,346 cr and EBITDA ₹219 cr, a significant improvement over FY24 revenue of ₹3,923 cr and EBITDA of ₹26 cr.
  2. R32 guidance Greenfield R32 project with investment of ₹340 cr, expected completion by October 2026.
  3. Rating downgrade CRISIL downgraded long-term ratings to A+ from AA- due to subdued performance.
  4. CMC growth Custom Manufactured Chemicals revenue grew over 80% in FY25, surpassing ₹500 cr milestone.
  5. PVC dumping Dumping of suspension PVC and paste PVC has created pricing pressures and margin compression.

Original filing on BSE

Chemplast Sanmar Limited Q1 FY27 results

As filed: Revenue ₹1,125 cr (+2% year on year), EBITDA −₹115 cr (−300% year on year), PAT −₹176 cr, EBITDA margin -10.2% (−1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹1,256 cr (+9% year on year), EBITDA ₹194 cr (+300% year on year), PAT −₹45.4 cr, EBITDA margin 15.5% (+1,000 bps). Score 87 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 1000 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −14.9% in 30 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹835 cr (−21% year on year), EBITDA −₹56.8 cr (−277% year on year), PAT −₹119 cr, EBITDA margin -6.8% (−982 bps). Score 13 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 982 bps year on year. Revenue fell 19% from last quarter. Share price after the results: −7.8% in 30 days (Nifty 500: −5.9%).
  • Q2 FY26: Revenue ₹1,033 cr (+4% year on year), EBITDA ₹43.0 cr (+65% year on year), PAT −₹51.0 cr, EBITDA margin 4.2% (+154 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was above it. EBITDA margin rose 154 bps year on year. Revenue fell 6% from last quarter. Share price after the results: −24.2% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹1,100 cr (−4% year on year), EBITDA ₹17.0 cr (−86% year on year), PAT −₹64.0 cr (−300% year on year), EBITDA margin 1.6% (−928 bps). Score 20 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA growth was well below it. EBITDA margin fell 928 bps year on year. Revenue fell 4% from last quarter. Share price after the results: −2.4% in 29 days (Nifty 500: −0.3%).
  • Q4 FY25: Revenue ₹1,151 cr (+10% year on year), EBITDA ₹37.0 cr (+76% year on year), PAT −₹54.0 cr, EBITDA margin 3.2% (+122 bps). Score 15 of 100, Below trend. Revenue growth was above the company's own trend. EBITDA margin rose 122 bps year on year. Share price after the results: +9.2% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹1,058 cr (+19% year on year), EBITDA ₹32.0 cr, PAT −₹49.0 cr, EBITDA margin 3.0% (+370 bps). Score 45 of 100, In line with trend. Revenue growth was well above the company's own trend. EBITDA margin rose 370 bps year on year.
  • Q2 FY25: Revenue ₹993 cr (+1% year on year), EBITDA ₹26.0 cr (−43% year on year), PAT −₹31.0 cr (−219% year on year), EBITDA margin 2.6% (−204 bps). Score 13 of 100, Below trend. EBITDA margin fell 204 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 13% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Chemplast Sanmar Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.